These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11443747)

  • 1. Clinical relevance of Fas (APO-1/CD95) expression in laryngeal squamous cell carcinoma.
    Jäckel MC; Mitteldorf C; Schweyer S; Füzesi L
    Head Neck; 2001 Aug; 23(8):646-52. PubMed ID: 11443747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression.
    Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W
    Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas expression is associated with a better prognosis in laryngeal squamous cell carcinoma.
    Asensio C; Zapata A; García-Ahijado J; Gil B; Salvadores P; Schneider J
    Anticancer Res; 2007; 27(6B):4083-6. PubMed ID: 18225575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.
    Loro LL; Vintermyr OK; Johannessen AC; Liavaag PG; Jonsson R
    J Oral Pathol Med; 1999 Feb; 28(2):82-7. PubMed ID: 9950255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue.
    Sundelin K; Jadner M; Norberg-Spaak L; Davidsson A; Hellquist HB
    Eur J Cancer; 1997 Oct; 33(11):1860-4. PubMed ID: 9470847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of Fas and FasL protein in squamous cell carcinoma of larynx].
    Shi L; Li G; Zhu C
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Dec; 16(12):661-2. PubMed ID: 12669436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
    Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
    Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
    Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of p53 in laryngeal carcinoma: clinicopathological implications.
    Dursun G; Sak SD; Akyol G; Dursun A; Erekul S; Demireller A; Akiner M
    Ear Nose Throat J; 1995 Sep; 74(9):645-8. PubMed ID: 8565866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report.
    Hellquist HB; Olejnicka B; Jadner M; Andersson T; Sederholm C
    Br J Cancer; 1997; 76(2):175-9. PubMed ID: 9231916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Fas protein in squamous cell carcinoma of the larynx.
    Bayazit Y; Mumbuç S; Uçak R; Kanlikama M; Bakir K
    Acta Otolaryngol; 2000 Jun; 120(4):557-61. PubMed ID: 10958412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis.
    Chen Q; Samaranayake LP; Zhen X; Luo G; Nie M; Li B
    Oral Oncol; 1999 Nov; 35(6):548-53. PubMed ID: 10705088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of FasL expression in oral squamous cell cancer.
    Fang L; Sun L; Hu FF; Chen QE
    Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cell death in NR-S1 tumor by photodynamic therapy: possible involvement of Fas and Fas ligand system.
    Yokota T; Ikeda H; Inokuchi T; Sano K; Koji T
    Lasers Surg Med; 2000; 26(5):449-60. PubMed ID: 10861700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer.
    Ohno S; Tachibana M; Shibakita M; Dhar DK; Yoshimura H; Kinugasa S; Kubota H; Masunaga R; Nagasue N
    Ann Surg Oncol; 2000 Dec; 7(10):750-7. PubMed ID: 11129423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin.
    Moers C; Warskulat U; Müschen M; Even J; Niederacher D; Josien R; Koldovsky U; Beckmann MW; Häussinger D
    Int J Cancer; 1999 Feb; 80(4):564-72. PubMed ID: 9935158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
    Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
    Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
    Kojc N; Zidar N; Vodopivec B; Gale N
    Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.
    Das SN; Khare P; Singh MK; Sharma SC
    Indian J Med Res; 2011 Jul; 134(1):54-60. PubMed ID: 21808135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.